Abstract
To evaluate the utility of screening for multiple gastrointestinal peptides in the evaluation of patients with chronic diarrhea, we studied 193 patients referred for evaluation of chronic diarrhea and eight patients with known peptide-secreting tumors as a reference group. Fasting plasma samples were assayed for motilin, neurotensin, pancreatic polypeptide, somatostatin, substance P, vasoactive intestinal polypeptide, gastrin-releasing peptide, and calcitonin during a protocol evaluation for causes of chronic diarrhea. Although none of the referred patients were found to have tumors, abnormal levels of one or more peptides were found in 86 of 193 patients (45%). Abnormal plasma peptide levels were sometimes as high in these patients as in patients with known peptide-secreting tumors and would have led to mistaken diagnoses of tumors much more often than they would have led to correct diagnoses. The positive predictive value of elevation of any assayed peptide was<2% at realistic prevalence rates for peptide-secreting tumors; the negative predictive value of a series of normal results was>99%, but much of this was due to the rarity of these tumors. Patients with chronic diarrhea should not be screened routinely with a panel of plasma peptide assays in an effort to detect tumors; instead, peptide levels should be ordered selectively. Elevated fasting concentrations of the plasma peptides measured in this study are most likely epiphenomena due to diarrhea and should not be the sole basis for invasive diagnostic or surgical management of these patients.
Similar content being viewed by others
References
Rambaud J-C, Hautefeuille M, Ruskone A, Jacquenod P: Diarrhoea due to circulating agents. Clin Gastroenterol 15:603–629, 1986
Eriksson B, Oberg K, Skogseid B: Neuroendocrine pancreatic tumors: Clinical findings in a prospective study of 84 patients. Acta Oncol 28:373–377, 1989
Vinik AI, Moattari AR: Neuroendocrine tumors, secretory diarrhea and responses to somatostatin.In Textbook of Secretory Diarrhea. E Lebenthal, ME Duffey (eds). New York, Raven Press, 1990, pp 309–324
Miller SM, O'Dorisio TM, Mekhjian HS, Thomas FB: VI-Poma syndrome.In Textbook of Secretory Diarrhea. E Lebenthal and ME Duffey (eds). New York, Raven Press, 1990, pp 325–335
Rood RP, Donowitz M: Endocrine tumor-associated diarrheal syndromes.In Diarrheal Diseases. M Field (ed). New York, Elsevier, 1991, pp 397–411
Koch TR, Michener SR, Go VLW: Plasma vasoactive intestinal polypeptide concentration determination in patients with diarrhea. Gastroenterology 100:99–106, 1991
Krejs GJ: Diarrhea.In Cecil Textbook of Medicine, 19th ed. JB Wyngaarden, LH Smith Jr, JC Bennett (eds). Philadelphia, WB Saunders, 1992, pp 680–687
Feldman JM, O'Dorisio TM: Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am J Med 81(suppl 6B):41–48, 1986
Chiang H-CV, O'Dorisio TM, Huang SC, Maton PN, Gardner JD, Jensen RT: Multiple hormone elevations in Zollinger-Ellison syndrome. Gastroenterology 99:1565–1575, 1990
Bostrom H, Oberg K: Neuroendocrine tumors of the gastrointestinal tract and pancreas. Tumor Biol 8:139–142, 1987
Read NW, Krejs GJ, Read MG, Santa Ana CA, Morawski SG, Fordtran JS: Chronic diarrhea of unknown origin. Gastroenterology 78:264–271, 1980
Ingelfinger JA, Mosteller F, Thibodeau LA, Ware JH: Biostatistics in Clinical Medicine. New York, Macmillan, 1987
Krejs GJ, Fordtran JS: Effect of VIP infusion on water and ion transport in the human jejunum. Gastroenterology 78:722–727, 1980
Besterman HS, Christofides ND, Welsby PD, Adrian TE, Sarson DL, Bloom SR: Gut hormones in acute diarrhoea. Gut 24:665–671, 1983
Walsh JH, Mayer EA: Gastrointestinal hormones.In Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, 5th ed. MH Sleisenger, JS Fordtran (eds). Philadelphia, WB Saunders, 1993, pp 18–44
Thompson WG, Heaton KW: Functional bowel disorders in apparently healthy people. Gastroenterology 79:283–288, 1980
Drossman DA, Sandler RS, McKee DC, Lovitz AJ: Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 83:529–534, 1982
Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ III: Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 101:927–934, 1991
Author information
Authors and Affiliations
Additional information
Supported by U.S. Public Health Service Grant 2-R01-DK37172-06 from the National Institute of Diabetes and Digestive and Kidney Diseases and by the Southwest Digestive Disease Foundation.
Rights and permissions
About this article
Cite this article
Schiller, L.R., Rivera, L.M., Santangelo, W.C. et al. Diagnostic value of fasting plasma peptide concentrations in patients with chronic diarrhea. Digest Dis Sci 39, 2216–2222 (1994). https://doi.org/10.1007/BF02090374
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02090374